Proteinuria During Sepsis and Septic Shock: Characterization and Association With ARDS
ALBUREA
1 other identifier
observational
100
1 country
1
Brief Summary
ARDS is a pulmonary edema injury. Among its etiologies, it can be secondary to septic shock. Managing septic shock involves hemodynamic optimization with significant fluid and sodium inputs. Fluid and sodium inputs in ARDS worsen respiratory failure through capillary leakage, and a restrictive input strategy is clinically beneficial (reduced mechanical ventilation duration and ICU stay). Predicting ARDS onset in septic shock allows for optimized fluid and sodium input management, adopting a restrictive rather than liberal approach to minimize deterioration in respiratory function.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 23, 2023
CompletedFirst Submitted
Initial submission to the registry
May 30, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2024
CompletedFirst Posted
Study publicly available on registry
June 27, 2024
CompletedJune 27, 2024
May 1, 2024
1 year
May 30, 2024
June 21, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Measurement of proteinuria in the first 24 hours (H0 and H24) of septic shock.
relationship between proteinuria kinetics in the first 24 hours (H0 and H24) of septic shock and presence of ARDS at H72
24 hours
Secondary Outcomes (3)
measurement of albuminuria urinary IgG at H0 and H24
24 hours
measurement of alpha-1-microglobulin at H0 and H24
24 hours
measurement of urinary IgG at H0 and H24
24 hours
Study Arms (1)
patients suspected of sepsis or septic shock
Eligibility Criteria
All adult patients suspected of sepsis or septic shock until 100 patients are enrolled. Infection diagnosis is based on systemic clinical signs (fever) or local inflammatory signs, biological evidence, and suspicion or confirmation of an infectious agent. The diagnosis of sepsis involves infection accompanied by organ failure, which may manifest as cardiovascular, respiratory, neurological, metabolic, renal, coagulation, or hepatic impairment. These signs may precede hypotension or occur without it.
You may qualify if:
- All patients aged 18 and older admitted to the intensive care unit for suspected sepsis or septic shock.
You may not qualify if:
- Minors or opposition to participation.
- Chronic dialysis patients
- Organ transplant recipients
- Confirmed urinary tract infection
- Subject with macroscopic hematuria
- Pregnant woman
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHI Andre Gregoire
Montreuil, 93100, France
Related Publications (1)
Iba T, Levy JH. Derangement of the endothelial glycocalyx in sepsis. J Thromb Haemost. 2019 Feb;17(2):283-294. doi: 10.1111/jth.14371. Epub 2019 Feb 3.
PMID: 30582882RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 30, 2024
First Posted
June 27, 2024
Study Start
May 23, 2023
Primary Completion
June 1, 2024
Study Completion
June 1, 2024
Last Updated
June 27, 2024
Record last verified: 2024-05